These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30312735)

  • 1. Aptamer-based proteomics of serum and plasma in acquired aplastic anemia.
    Giudice V; Biancotto A; Wu Z; Cheung F; Candia J; Fantoni G; Kajigaya S; Rios O; Townsley D; Feng X; Young NS
    Exp Hematol; 2018 Dec; 68():38-50. PubMed ID: 30312735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy.
    Yamazaki H; Ohta K; Iida H; Imada K; Obara N; Tokumine Y; Tomiyama Y; Usuki K; Imajo K; Miyamura K; Sasaki O; Fanghong Z; Hattori T; Tajima T; Matsuda A; Nakao S
    Int J Hematol; 2019 Aug; 110(2):187-196. PubMed ID: 31183813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 4. Eltrombopag in children with severe aplastic anemia.
    Lesmana H; Jacobs T; Boals M; Gray N; Lewis S; Ding J; Kang G; Hale M; Weiss M; Reiss U; Wang W; Wlodarski M
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29066. PubMed ID: 33855784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
    Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
    N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of eltrombopag in severe aplastic anemia.
    Scheinberg P
    Blood Adv; 2018 Nov; 2(21):3054-3062. PubMed ID: 30425070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
    Geng W; Kearney S; Nelson S
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aplastic Anemia.
    Young NS
    N Engl J Med; 2018 Oct; 379(17):1643-1656. PubMed ID: 30354958
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of eltrombopag in severe aplastic anemia.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):450-456. PubMed ID: 30504345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent issues and prospects of the treatment of aplastic anemia].
    Nakao S
    Rinsho Ketsueki; 2014 Jan; 55(1):5-11. PubMed ID: 24492031
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombopoietin receptor agonist arouses new hope].
    Häckel A
    MMW Fortschr Med; 2016 Apr; 158(7):73. PubMed ID: 27071600
    [No Abstract]   [Full Text] [Related]  

  • 13. Eltrombopag in aplastic anemia.
    Desmond R; Townsley DM; Dunbar C; Young NS
    Semin Hematol; 2015 Jan; 52(1):31-7. PubMed ID: 25578417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Serum Interleukin-6 Predicts Favorable Response to Immunosuppressive Therapy in Children With Aplastic Anemia.
    Lu S; Qiao X; Xie X
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):614-617. PubMed ID: 29068868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
    Peffault de Latour R; Huynh L; Ivanova JI; Totev T; Bilginsoy M; Antin J; Roy A; Duh MS
    Ann Hematol; 2020 Apr; 99(4):743-752. PubMed ID: 32065291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia.
    Huang Z; Tong H; Li Y; Zhou H; Qian J; Wang J; Ruan J
    Hematology; 2017 Aug; 22(7):430-436. PubMed ID: 28211781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.
    Fattizzo B; Kulasekararaj AG; Hill A; Benson-Quarm N; Griffin M; Munir T; Arnold L; Riley K; Ireland R; De Lavallade H; Potter V; Consonni D; Hillmen P; Mufti GJ; Barcellini W; Marsh JCW
    Haematologica; 2019 Nov; 104(11):e494-e496. PubMed ID: 30890599
    [No Abstract]   [Full Text] [Related]  

  • 18. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
    Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
    Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
    Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
    Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.